Live Breaking News & Updates on Stellanova Therapeutics Inc
Stay updated with breaking news from Stellanova therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Finance Watch: 3T Biosciences Emerges With $40m And Novel TCR Platform informa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from informa.com Daily Mail and Mail on Sunday newspapers.
Stellanova Therapeutics Closes $15.5M Series A Financing Round The round was led by Sporos Bioventures. The company intends to use the funds to advance its lead antibody asset to first-in-human clinical trials for oncology, establish its discovery platform, and build its team. Led by Rosa Hwang, M.D., co-founder, Stellanova is focused on targeting the many pro-tumorigenic effects enabled by the activity of carcinoma-associated fibroblasts (known as CAFs) in the tumor microenvironment. CAFs play essential roles in promoting cancer growth and metastasis, spurring angiogenesis, suppressing anti-tumor immunity, and fostering chemoresistance. The company’s lead antibody candidate is designed to neutralize DKK3, a factor secreted by CAFs that acts on neighboring cancer cells and immune cells to promote tumor progression and therapy resistance. In pre-clinical studies, treatment with anti-DKK3 monoclonal antibody and immune checkpoint inhibitor therapy has produced sustain ....